<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03240250</url>
  </required_header>
  <id_info>
    <org_study_id>3564</org_study_id>
    <nct_id>NCT03240250</nct_id>
  </id_info>
  <brief_title>Randomized Study on Effects of Uniportal VATS Versus Triportal VATS</brief_title>
  <official_title>Randomized Study on Effects of Uniportal VATS Versus Triportal VATS for the Treatment of Stage I-II NSCLC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      For the treatment of stage I-II NSCLC, two mini-invasive techniques are mostly utilized:
      uni-portal and three-portal VATS. In the uniportal approach, the injury on a single
      intercostal space could determine a lower level of pain than the three-portal approach,
      allowing a better postoperative course. Few studies in Literature compare these techniques,
      and most of them are retrospective.

      The main purpose of this randomized study is to compare uni-portal VATS with three-portal
      VATS, in terms of postoperative pain.

      Secondary objectives of the study are valutations of:

        -  respiratory and functional capacity between the two groups

        -  operative time

        -  number of resected lymphnodes

        -  intra and postoperative complications, such as conversions to open surgery, amount of
           bleeding, prolonged air leaks, surgical site infections, pulmonary complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized cohort clinical trial, prospectic, monocentric. Procedure of randomization: the
      day before the operation, with the &quot;Random Allocation Rule&quot; technique

      Arm 1: pulmonary lobectomy and lymphoadenectomy with uni-portal VATS approach

      Arm 2: pulmonary lobectomy and lymphoadenectomy with three-portal VATS approach

      Misurations Total analgesic consumption, normalized to morphine milligrams, recorded in the 7
      days following the operation.

      The choice of cumulative analgesic consumption as parameter of primary outcome is because
      pain valuation with VAS is significantly affected by individual variability.

      Secondary outcomes: measure of postoperative pain with NRS at 2,6,12,24 hours and at
      2,3,4,5,30 days from sugery. A pain score will be assigned to each patient after the total
      amount of NRS.

      Respiratory function will be valuated with spirometry after 7 and 30 days from surgery, and
      compared with pre-operative tests.

      All intraoperative parameters will be compared between the two groups: operative time (skin
      to skin), proportion of conversions to open surgery, number of resected lymphnodes, amount of
      bleeding.

      Postoperative complications will be analyzed: rate of prolonged air leaks, surgical site
      infections, cardiac rythhm disfunctions, pulmonary complications, post-thoracotomy syndrome,
      as well as lenght of stay at the hospital.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2017</start_date>
  <completion_date type="Anticipated">May 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of postoperative pain after uni-portal and three-portal VATS</measure>
    <time_frame>7 days</time_frame>
    <description>Total analgesic consumption, normalized to morphine milligrams, recorded in the 7 days following the operation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure of postoperative pain with NRS at 2,6,12,24 hours and at 2,3,4,5,30 days from sugery.</measure>
    <time_frame>30 days</time_frame>
    <description>A pain score will be assigned to each patient after the total amount of NRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Valuation of respiratory function</measure>
    <time_frame>30 days</time_frame>
    <description>Spirometry after 7 and 30 days from surgery, compared with pre-operative tests</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative parameters</measure>
    <time_frame>1 day</time_frame>
    <description>Operative time (skin to skin, minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative bleeding</measure>
    <time_frame>1 day</time_frame>
    <description>Amount of bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative air leakage</measure>
    <time_frame>15 days</time_frame>
    <description>Rate of prolonged air leaks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>1 month</time_frame>
    <description>Cardiac rythhm disfunctions</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Uni-portal VATS</arm_group_label>
    <description>VATS uni-portal lobectomy and lymphoadenectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Three-portal VATS</arm_group_label>
    <description>VATS three-portal lobectomy and lymphoadenectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VATS uni-portal lobectomy and lymphoadenectomy</intervention_name>
    <description>VATS uni-portal lobectomy and lymphoadenectomy</description>
    <arm_group_label>Uni-portal VATS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VATS three-portal lobectomy and lymphoadenectomy</intervention_name>
    <description>VATS three-portal lobectomy and lymphoadenectomy, Copenhagen approach</description>
    <arm_group_label>Three-portal VATS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with clinical diagnosis of NSCLC, stage I-II, age 30-75, who undergo pulmonary
        lobectomy and limphadenectomy with radical intent
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cT1-2N0-1M0 NSCLC, maximum diameter 5cm

          -  ASA (American Society of Anestesiology) score 1-2-3

        Exclusion Criteria:

          -  N2-N3 disease

          -  Induction chemotherapy

          -  Thoracic wall infiltration

          -  Previous thoracic surgery

          -  Important pleural adhesions

          -  Severe COPD, asthma, interstitial lung disease - Liver, kidney or cardiac failure

          -  Clotting disorders

          -  Analgesic allergy

          -  Sublobar resection, sleeve lobectomy, pneumonectomy

          -  Chronic analgesic, oppioids or cortisonic use

          -  Absence of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davide Tosi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione Ca' Granda IRCCS Policlinico Milan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Davide Tosi, MD</last_name>
    <phone>+393387335864</phone>
    <email>davide.tosi@policlinico.mi.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mario Nosotti, Professor</last_name>
    <phone>+39255034056</phone>
    <email>mario.nosotti@unimi.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Thoracic Surgery Unit - Fondazione IRCCS Ca' Granda Policlinico</name>
      <address>
        <city>Milan</city>
        <state>Mi</state>
        <zip>20100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide Tosi</last_name>
      <phone>3387335864</phone>
      <email>davide.tosi@policlinico.mi.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2017</study_first_submitted>
  <study_first_submitted_qc>August 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2017</study_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>VATS</keyword>
  <keyword>Pulmonary lobectomy</keyword>
  <keyword>Uniportal</keyword>
  <keyword>Postoperative pain</keyword>
  <keyword>Thoracic surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

